Form D · Pharmaceuticals
Arno Therapeutics, Inc
Flemington, NJ · CIK 0001195116
Offering snapshot reported Aug 30, 2016 · SEC filing
- Reported sold
- $4.51M Offering amount: $4.51M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 15, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 30, 2016 | Initial | $4,510,182 | No comparison | 15 | SEC filing |
| Nov 13, 2013 | Initial | $30,840,078 | No comparison | 69 | SEC filing |
| Dec 6, 2012 | Amendment | $11,130,000 | $0vs Dec 5, 2012 | 16 | SEC filing |
| Dec 5, 2012 | Initial | $11,130,000 | No comparison | 16 | SEC filing |
| Sep 23, 2010 | Initial | $8,387,000 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-269798
Includes the amount that may be received upon the future exercise of warrants.
Source: Form D, filed Aug 30, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arie S. Belldegrun | Director |
| Arie S. Belldegrun, M.D. | Director |
| Robert I. Falk | Director |
| William F. Hamilton | Director |
| William F. Hamilton, Ph.D. | Director |
| Tomer Kariv | Director |
| Peter M. Kash | Director |
| Joshua A. Kazam | Director |
| Glenn R. Mattes | Director, Executive |
| Jay Moorin | Director |
| Scott L. Navins | Executive |
| Stefan Proniuk, Ph.D. | Executive |
| Yacov Reizman | Director |
| Steven B. Ruchefsky | Director |
| David M. Tanen | Director |
| Randy H. Thurman | Director |
| Alexander Zukiwski, M.D. | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
200 Route 31 North Suite 104
Flemington, NJ, 08822
Flemington, NJ, 08822